Firas Zahr, M.D., says data from the first 15 patients in an early feasibility study of a transcatheter mitral valve replacement system indicate the system is “a promising option."

Firas Zahr, M.D., says data from the first 15 patients in an early feasibility study of a transcatheter mitral valve replacement system indicate the system is “a promising option."

A study by Benjamin Wang, M.D., finds that most pregnant women who thought they were allergic to penicillin are not, and suggests that only people with group B Streptococus should undergo a graded oral amoxicillin challenge.

In response to a recent event where the public paid to observe an autopsy at a Portland hotel, in which OHSU was not involved, Tamara Ostervoss says: “Obviously, the ethics of that are incredibly questionable,” damaging “public trust, and that has far-reaching consequences."

Study led by Ximena Levander, M.D., and Jarratt Pytell, M.D., finds new opioid treatment program leaders resist improving access to methadone, even though loosening of federal regulations allow more patients to administer the treatment at home during the pandemic.

Nov. 4 modeling by Peter Graven, Ph.D., shows approval of COVID-19 vaccines for children ages 5 to 11 will help slow the transmission of the disease, and his Oct. 28 modeling indicates Central and South Central Oregon were lagging behind the rest of the state in terms of reduced hospitalizations.

OHSU is among many transplant centers nationwide that require COVID-19 vaccination as condition to organ transplantation.

Rodney Pommier, M.D., and Sarah Wonn, M.D., discuss the implications of their new study findings on how carcinoid crisis should be prevented and treated now and in the future in patients with neuroendocrine tumors.

In a video interview with Pharmacy Times, Rodney Pommier, M.D., discusses the implications of his study findings in relation to how carcinoid crisis should be prevented and treated now and in the future.

Kimberly Winges, M.D., describes the increasing number of treatment and diagnostic options available in the neuro-opthalmology subspecialty, including treatments for giant cell arteritis and thyroid eye disease.